Casandra
Casandra Test Code QD98292Version 1 (DRAFT)
Performing Lab
SARS‑CoV‑2 RNA (COVID‑19) and Respiratory Viral Panel, Qualitative NAAT
Also known as: Parainfluenza, Novel Coronavirus, Adenovirus, Wuhan, COVID19
Clinical Use
Order TestUse
This qualitative nucleic acid amplification test (NAAT) detects SARS‑CoV‑2 RNA along with multiple other respiratory viral pathogens in a single specimen, facilitating differential diagnosis of COVID‑19 versus other viral infections; aids timely clinical decision‑making in patients presenting with acute respiratory symptoms.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
PCR-based (PCR)
Biomarkers
13 targets
AdenovirusHuman MetapneumovirusHuman Parainfluenza Virus 1Human Parainfluenza Virus 2Human Parainfluenza Virus 3Human RSV AHuman RSV BInfluenza A+5 more
Result Turnaround Time
2-3 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Nasal Swab
Volume
Not provided
Minimum Volume
Not provided
